WHRIA has a strong history of clinical research across a broad range of fields. Our focus on clinical research fosters new ideas for clinical research for the diagnosis, treatment and management of a broad range of conditions. Through clinical research studies we can trial and these ideas, then apply them in our clinic to continually improve the service we provide you.Read More
WHRIA has a long history of conducting innovative clinical research in women’s health. We often work in collaboration with University of New South Wales’ Barbara Gross Research Unit.Read More
See our Clinical Studies to see if you would like to participate in any of our current trials.
Here’s how new ideas emerge, and how we bring our innovative research to life:
New ways of diagnosing, treating and managing conditions need to be trialled and tested to ensure the safety and effectiveness before we can use them in the clinic.
Innovative approaches are implemented in the WHRIA clinic as pilot studies, often evolving into full large-scale clinical trials. To complete the circle, we continually update WHRIA treatment protocols, according to the results of our ongoing research and any new research worldwide.
WHRIA is continually working towards the best outcomes for everyone who comes to the clinic as well as the broader community.
The first Botulinum Toxin Type A use in the pelvic floor muscles introduced by Ms Sherin Jarvis and Professor Thierry Vancaillie via a pilot study in 2002. This went on to become a randomised controlled trial, which was ground-breaking research in pelvic pain, world-wide. It is now used throughout the world as an important treatment option for chronic pelvic pain in both men and women.
Speak to us if you’d like to speak to one of our friendly staff regarding our current trialClick Here